EUVIMEDEUVIMED entdecken
Crossref

Clinical Association Between Immune-related Adverse Events and Treatment Efficacy in Patients With Non-small-cell Lung Cancer Treated With Nivolumab-Ipilimumab-based Therapy

Noriyuki Ebi, Hiroyuki Inoue, Fumiyasu Igata, Rei Okuma, Eriko Kinoshita, Toshiaki Kawabata, Ibun Tan, Yusuke Osaki, Takato Ikeda, Akira Nakao, Yuki Shundo, Naoki Hamada und 1 weitere

Anticancer Research · 2024

DOI: 10.21873/anticanres.17122 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Anticancer Research, 2024. Verfasst von Noriyuki Ebi und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Medicine, Fukuoka University Hospital, Fukuoka, Japan. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Ipilimumab, Nivolumab. Die Arbeit wurde bisher 6-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungLung NeoplasmsIpilimumabNivolumabAntineoplastic Agents, ImmunologicalHumansFemaleAdultMiddle AgedAgedAged, 80 and overProgression-Free SurvivalTreatment OutcomeAntineoplastic Combined Chemotherapy Protocols

Stichwörter der Autor:innen

Advanced non-small-cell lung cancerinterstitial lung diseasemultivariate analysisreal-world clinical settingretrospective analysis

Substanzen

IpilimumabNivolumabAntineoplastic Agents, Immunological

Autor:innen und Institutionen

  • Department of Respiratory Medicine, Fukuoka University Hospital, Fukuoka, Japan.
  • Department of Respiratory Medicine, Fukuoka University Hospital, Fukuoka, Japan hinoue@fukuoka-u.ac.jp.

Zitieren

APA

Ebi, N., Inoue, H., Igata, F., Okuma, R., Kinoshita, E., Kawabata, T., Tan, I., Osaki, Y., Ikeda, T., Nakao, A., Shundo, Y., Hamada, N., & Fujita, M. (2024). Clinical Association Between Immune-related Adverse Events and Treatment Efficacy in Patients With Non-small-cell Lung Cancer Treated With Nivolumab-Ipilimumab-based Therapy. Anticancer Research. https://doi.org/10.21873/anticanres.17122

Vancouver

Ebi N, Inoue H, Igata F, Okuma R, Kinoshita E, Kawabata T, et al. Clinical Association Between Immune-related Adverse Events and Treatment Efficacy in Patients With Non-small-cell Lung Cancer Treated With Nivolumab-Ipilimumab-based Therapy. Anticancer Research. 2024. doi:10.21873/anticanres.17122

BibTeX
@article{Ebi2024,
  author = {Ebi, Noriyuki and Inoue, Hiroyuki and Igata, Fumiyasu and Okuma, Rei and Kinoshita, Eriko and Kawabata, Toshiaki and Tan, Ibun and Osaki, Yusuke and Ikeda, Takato and Nakao, Akira and Shundo, Yuki and Hamada, Naoki and Fujita, Masaki},
  title = {Clinical Association Between Immune-related Adverse Events and Treatment Efficacy in Patients With Non-small-cell Lung Cancer Treated With Nivolumab-Ipilimumab-based Therapy},
  journal = {Anticancer Research},
  year = {2024},
  doi = {10.21873/anticanres.17122}
}
Kostenlos starten →